Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 3Phase 1 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Fallopian Tube Neoplasms 2Successful Conversion Rate of Operation 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cyclophosphamide 4Rituximab 3Vincristine 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Immunotherapy, Adoptive 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Doxorubicin 2tisagenlecleucel 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1oblimersen 1ibritumomab tiuxetan 1duvelisib 1Surveys and Questionnaires 1Sugars 1Specimen Handling 1Radiation 1Pemetrexed 1Nivolumab 1NVP-BKM120 1Microarray Analysis 1Methotrexate 1Loratadine 1Leukapheresis 1Immunohistochemistry 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lymphoma, Large B-Cell, Diffuse × Drug Therapy × Clear all
NCT02405078 2022-10-28

Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
35 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡